Taken together, our results suggest that IL-6 knockdown can increase chemo-drug efficacy, reduce drug resistance, inhibit tumor growth and reduce the potential for tumor recurrence and metastasis in laryngeal cancer. This evidence concerns the gene IL6 and neoplasm.